Search clinical trials for: AG-881

Total 897 results

American Genomics, LLC

Completed

An Open Label, Study of the Systemic Exposure to Articaine After Topical Ocular Dosing of AG-920

Healthy

United States
Agios Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Mitapivat (AG-348) in Healthy Adult Participants

Healthy Volunteers

United States
Agios Pharmaceuticals, Inc.

Completed

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120

Healthy Volunteers

United States
Pfizer

Completed

Evaluation Of Hepatic Impairment On AG-013736 Pharmacokinetics

Hepatic Insufficiency

United States
National Cancer Institute (NCI)

Completed

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Breast Carcinoma | Ovarian Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative... and other conditions

United States
Daniel Stephan Engeler

Completed

Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors

Neoplasm of Lateral Wall of Urinary Bladder

Switzerland
Lynkcell Europe

Enrolling by invitation

Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations

Breast Cancer | Breast Neoplasms | Ovarian Neoplasms | Ovarian Cancer | HER2-positive Breast Cancer | HER2-negative Breast Cancer | HER-2 Protein Overexpression | BRCA Mutation

Ukraine
Pfizer

Completed

Food Effect Study Of AG-013736 In Healthy Volunteers

Healthy Volunteers

Belgium
Altor BioScience
National Cancer Institute (NCI)

Terminated

QUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma

United States
AbbVie

Completed

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Advanced Solid Tumors

United States, Australia, Austria, Belgium, Canada, Finland, France, Japan, Spain, Taiwan
Institut de Recherches Internationales Servier

Active, not recruiting

Study of AG-120 and AG-881 in Subjects With Low Grade Glioma

Glioma

United States
M.D. Anderson Cancer Center
Pfizer

Completed

Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)

Kidney Cancer

United States
National Institute of Allergy and Infectious Diseases...
Immuno-US

Completed

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals

HIV Infections

United States
Sheffield Teaching Hospitals NHS Foundation Trust
Pfizer; Cancer Research UK; University of Birmingham

Completed

A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas (Axi-STS)

Soft Tissue Sarcoma

United Kingdom
Yale University

Withdrawn

A Study of the IDH1 Inhibitor AG-120 in Combination With the Checkpoint Blockade Inhibitor, Nivolumab, for Patients With IDH1 Mutated Relapsed/Refractory AML and High Risk MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaborators

Completed

Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth

HIV Infection | Hepatitis B

Brazil, United States, South Africa
Bern University of Applied Sciences
Goethe University; Maastricht University Medical Center; Swiss Federal Institute...

Completed

Innovative Training Program for Elderly in Need of Care Individuals

Muscle Weakness | Poor Performance Status

Switzerland
Pfizer

Completed

Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer

Kidney Neoplasms | Carcinoma, Renal Cell

United States
ULURU Inc.

Terminated

Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl (ROM)

Burn

United States
Pfizer

Completed

A Bioequivalence Study Of AG-013736 Tablets Under Fed Conditions In Healthy Volunteers

Healthy Volunteer

Singapore
OncoC4, Inc.

Not yet recruiting

Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

Advanced Solid Tumor

United States
AbbVie

Completed

A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors

Advanced Solid Tumors

Japan
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
Maastricht University Medical Center
Dutch Heart Foundation; Center for Translational Molecular Medicine

Completed

ParisK: Correlation of Imaging Techniques With Histology (ParisK)

Stroke | Plaque, Atherosclerotic

Netherlands
University Health Network, Toronto
Pfizer

Completed

Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma (AXITINIB)

Hepatocellular Carcinoma

Canada
University Hospital Heidelberg

Completed

A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. EMCOOLS Brain.Pad (iCOOL 3) (iCOOL 3)

Ischemic Stroke | Hemorrhagic Stroke

Germany
Pfizer

Completed

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Melanoma | Skin Neoplasms

United States, France
Pfizer

Completed

Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors

Carcinoma

Japan
Sucampo Pharma Americas, LLC

Terminated

Cobiprostone for the Prevention of Oral Mucositis in Subjects With Head and Neck Cancer Receiving Concurrent Radiation and Chemotherapy

Oral Mucositis

United States
Columbia University
Pfizer

Recruiting

Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma

Pheochromocytoma | Paraganglioma

United States
Agios Pharmaceuticals, Inc.

Active, not recruiting

A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia

Thalassemia

United States, Canada, United Kingdom
Northwestern University

Terminated

Anterior-segment OCT (AS-OCT) and Intraoperative OCT (iOCT) for Trans- Conjunctival Needle Revision (TCNR)

Glaucoma | Glaucoma Following Surgery

United States
Indiana University
University of Alabama at Birmingham; University of Ottawa

Completed

G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis

Progressive Multiple Sclerosis

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

HIV Infections

United States
Pfizer

No longer available

Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment

Renal Cell Carcinoma

Australia, Canada
Pfizer

Completed

Axitinib Pharmacokinetics in Chinese Healthy Volunteers

Healthy Volunteers

China
Nektar Therapeutics

Completed

A Phase 2 Study To Assess The Efficacy, Tolerability, And Safety OF NKTR-181 In Subjects With Chronic OA Knee Pain

Osteoarthritis of the Knee

United States
National Cancer Institute (NCI)

Completed

Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma

Pheochromocytoma | Paraganglioma

United States
Rothman Institute Orthopaedics

Unknown

A Comparative Study to Assess the Prevention of Surgical Site Infection (SSI's) in Revision Total Joint Arthroplasty Patients Treated With Single-Use Negative Pressure Wound Therapy (PICO™) or Standard Care Dressings (AQUACEL® Ag SURGICAL Dressing)

Surgical Wound Infection

United States
Firat University
Dicle University

Completed

Associations of Alveolar Bone Loss and Interleukin-1β Levels in One and Two Stage Surgical Procedures

Alveolar Bone Loss | Implant Infection

Turkey
Pfizer

Withdrawn

A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)

Diabetes Mellitus | Diabetic Retinopathy
Pfizer

Completed

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Thyroid Neoplasms

United States, Canada, Czech Republic, Poland, China, Italy, Spain, India, United Kingdom
Pfizer

Completed

A Study In Patients With Advanced Solid Tumor

Neoplasms

Japan
Pfizer

Completed

First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors

Advanced Solid Tumors

United States
Tyme, Inc

Withdrawn

Study of SM-88 in Advanced Cancers

Breast Cancer
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Neuroblastoma | High-risk Neuroblastoma | Metastatic Neuroblastoma

United States
Samsung Medical Center

Recruiting

Effect of Prophylactic Medical Compression Therapy on the Reduction of Breast Cancer-related Lymphedema in Patients With Adjuvant Docetaxel Chemotherapy: a Randomized Controlled Study

Breast Cancer Lymphedema

Korea, Republic of
Avita Medical
Biomedical Advanced Research and Development Authority

Terminated

RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years

Burns

United States
Pfizer

Completed

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

Kidney Neoplasms

Korea, Republic of, United States, Canada, Spain, Italy, United Kingdom, China, Singapore, Slovakia, France, Japan, Australia, Germany, Taiwan, Brazil, Russian Federation, India, Poland, Austria, Greece, Ireland, Sweden
Pfizer

Terminated

PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States, Czechia

Search clinical trials for: AG-881

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations